日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of Circulating Tumor DNA and Copy-Number Alterations on Clinical Outcome in Relapsed/Refractory Germ Cell Tumors Treated With Salvage High-Dose Chemotherapy

循环肿瘤DNA和拷贝数改变对接受挽救性大剂量化疗的复发/难治性生殖细胞肿瘤临床结局的影响

Urbini, Milena; Eleveld, Thomas F; Polano, Maurizio; Scarpi, Emanuela; Menna, Cecilia; Gianni, Caterina; Janssen, Ferdinand W; Schepisi, Giuseppe; Gurioli, Giorgia; Kucerova, Lucia; Gillis, Ad J M; Virga, Alessandra; Bleve, Sara; Rosti, Giovanni; Ulivi, Paola; Mego, Michal; Looijenga, Leendert H J; De Giorgi, Ugo

Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells.

Mirvetuximab Soravtansine 对顺铂耐药生殖细胞肿瘤细胞具有强大的细胞毒性和旁观者效应

Kucerova Lucia, Fekiacova Adriana, Udvorkova Natalia, Malcharkova Pavlina, Blahova Viktoria, Jochova Silvia, Kalavska Katarina, Cierna Zuzana, Mego Michal

Correction: Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

更正:血浆DNase水平低与睾丸生殖细胞肿瘤患者较差的临床预后相关,外源性DNase I可提高顺铂治疗的疗效。

Mego, Michal; Vlkova, Barbora; Kalavska, Katarina; Pastorek, Michal; Cierna, Zuzana; Sestakova, Zuzana; Chovanec, Miroslav; Udvorkova, Natalia; Kucerova, Lucia; Celec, Peter

Low level of plasma DNase is associated with worse clinical outcome in testicular germ cell tumor patients and exogeneous DNase I improves cisplatin treatment efficacy

睾丸生殖细胞肿瘤患者血浆中DNase水平低与较差的临床预后相关,而外源性DNase I可提高顺铂治疗的疗效。

Mego, Michal; Vlkova, Barbora; Kalavska, Katarina; Pastorek, Michal; Cierna, Zuzana; Sestakova, Zuzana; Chovanec, Miroslav; Udvorkova, Natalia; Kucerova, Lucia; Celec, Peter

Molecular features and gene expression signature of metastatic colorectal cancer (Review)

转移性结直肠癌的分子特征和基因表达谱(综述)

Poturnajova, Martina; Furielova, Tatiana; Balintova, Sona; Schmidtova, Silvia; Kucerova, Lucia; Matuskova, Miroslava

Recent advances in understanding tumor stroma-mediated chemoresistance in breast cancer

近年来,人们对乳腺癌肿瘤基质介导的化疗耐药性有了更深入的了解。

Plava, Jana; Cihova, Marina; Burikova, Monika; Matuskova, Miroslava; Kucerova, Lucia; Miklikova, Svetlana

Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells.

双硫仑克服人类胚胎癌细胞的顺铂耐药性

Schmidtova Silvia, Kalavska Katarina, Gercakova Katarina, Cierna Zuzana, Miklikova Svetlana, Smolkova Bozena, Buocikova Verona, Miskovska Viera, Durinikova Erika, Burikova Monika, Chovanec Michal, Matuskova Miroslava, Mego Michal, Kucerova Lucia

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma

HGF/c-MET酪氨酸激酶抑制剂在转移性黑色素瘤中的作用

Demkova, Lucia; Kucerova, Lucia

Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

酪氨酸激酶抑制剂 SU11274 通过生物能量调节增加致瘤性并富集黑色素瘤起始细胞

Lucia Kucerova, Lucia Demkova, Svetlana Skolekova, Roman Bohovic, Miroslava Matuskova

The docking protein and proto-oncogene product Gab2 is regulated via a novel negative feedback mechanism mediated by 14-3-3 binding

对接蛋白和原癌基因产物Gab2通过一种由14-3-3蛋白结合介导的新型负反馈机制进行调控。

Skolekova, Svetlana; Matuskova, Miroslava; Bohac, Martin; Toro, Lenka; Durinikova, Erika; Tyciakova, Silvia; Demkova, Lucia; Gursky, Jan; Kucerova, Lucia; Kroening, S; Streiff, C; Goppelt-Struebe, M; Brummer, T; Larance, M; Abreu, MT Herrera; Lyons, RJ; Timpson, P; Emmerich, CH; Fleuren, EDG; Lehrbach, GM; Schramek, D; Guilhaus, M; James, DE; Daly, RJ